ENTITY
Pacific Edge

Pacific Edge (PEB NZ)

50
Analysis
Health CareNew Zealand
Pacific Edge Ltd is a biomedical company specialising in the discovery and commercialisation of diagnostic and prognostic technology for the early detection and monitoring of cancer. The Company has completed successful trials in bladder cancer detection and colorectal cancer prognosis.
more
Refresh
bearishPacific Edge
29 Dec 2023 07:59Broker

Pacific Edge - Rubber Approaching the Road

Pacific Edge’s (PEB) 2Q24 test volumes highlighted slowing momentum with +8% year on year growth and a -12% sequential decline.

Logo
479 Views
Share
bullishPacific Edge
24 Nov 2023 07:35Broker

Pacific Edge - 1H24 Result — Kaiser Time

While it has undertaken significant cost reductions to right size the business and manage cash flow this was not seen in its 1H24 result, with most...

Logo
407 Views
Share
bearishPacific Edge
15 Jul 2023 20:00Broker

Pacific Edge (PEB): LCD Update – Signs of Life

The implementation of LCD, L35396 “Genetic Testing for Oncology” that would have resulted in Pacific Edge’s (PEB) CMS reimbursement ceasing on 17...

Logo
341 Views
Share
bullishPacific Edge
17 Jun 2023 20:00Broker

Pacific Edge: CMiSery

Pacific Edge's (PEB) CMS reimbursement will cease effective 17 July 2023. Materiality is very high — our prior base case assumed CMS would...

Logo
360 Views
Share
bearishPacific Edge
17 Jun 2023 20:00Broker

Pacific Edge (PEB): Medicare Response − Bad News Confirmed

Pacific Edge (PEB) has confirmed the finalisation of Novitas' Local Coverage Determination (LCD); Its response to the market this morning dit not...

Logo
363 Views
Share
x